Dr. Awanish Kumar – Drug Discovery and development – Excellence in Research

Dr. Awanish Kumar - Drug Discovery and development - Excellence in Research

NIT Raipur - India

Author Profile

SCOPUS 

ORCID 

🌱 Early academic pursuits

Dr. Awanish Kumar's journey into biotechnology began with an m.sc. in biotechnology from devi ahilya university, indore, where he graduated with first division honors, securing an impressive 75.9%. his thirst for knowledge and passion for research led him to pursue a ph.d. at the prestigious jawaharlal nehru university (jnu), new delhi, and the central drug research institute (cdri), lucknow. during this time, he delved deeply into biotechnology, laying a strong foundation for his future research in antifungal therapeutics and microbial biology.

👨‍🏫 Professional endeavors

currently, Dr. Awanish kumar serves as an associate professor at the department of biotechnology, national institute of technology (nit), raipur. since april 2022, he has been mentoring students, guiding cutting-edge research, and contributing to the growth of the department. his academic career also includes a post-doctoral fellowship at jnu, where he worked on a ugc-funded project investigating the antifungal properties of curcumin, a bioactive compound from curcuma longa.

🔬 Contributions and research focus

Dr. Kumar’s research is centered around antimicrobial peptides, drug delivery systems, and antifungal therapeutics. under his mentorship, two ph.d. students Drug Discovery and development completed their research on topics like the isolation of antifungal peptides from microbes and the design of biopolymeric microneedle patches for transdermal drug delivery. his ongoing projects include studies on biofilm disruption, redox nanomaterials, and the evaluation of natural compounds for their antifungal properties. one of his notable research contributions is demonstrating how curcumin induces apoptosis in candida albicans by generating reactive oxygen species and activating caspase-3.

🏆 Accolades and recognition

dr. Kumar’s achievements in research have not gone unnoticed. he was awarded the prestigious ugc ds kothari fellowship, recognizing him as an emerging young Drug Discovery and development investigator. this fellowship provided him the opportunity to lead significant research on antifungal mechanisms, especially curcumin’s role in modulating efflux activities in candida albicans. his innovative work on biopolymers and antifungal biomaterials has earned him acclaim in academic circles.

🌍 Impact and influence

Dr. Kumar’s work in biotechnology, particularly his studies on antifungal peptides and curcumin’s therapeutic potential, has significant implications in both medicine and agriculture. his pioneering efforts in designing biopolymeric patches for drug delivery and developing antifungal biomaterials are set to influence future research in fungal pathogen treatment. he continues to inspire the next generation of researchers through his mentorship and collaborative projects in microbial biotechnology.

💡 Legacy and future contributions

Dr. Kumar's contributions to antifungal research and biopharmaceutical sciences are building a legacy in microbial biotechnology. with three ongoing ph.d. projects under his guidance and several groundbreaking discoveries already under his belt, he is shaping the future of antifungal therapeutics. his focus on developing Drug Discovery and development commercial applications for antifungal biomaterials highlights his forward-thinking approach and commitment to bringing research from the lab to real-world applications.

Notable Publications

  1. Title: Acetaminophen induces mitochondrial apoptosis through proteasome dysfunctions
    Authors: Jagtap, Y.A., Kumar, P., Dubey, A.R., Prasad, A., Mishra, A.
    Journal: Life Sciences, 2024, 349, 122732
  2. Title: Nanomaterials-Based Hybrid Bioink Platforms in Advancing 3D Bioprinting Technologies for Regenerative Medicine
    Authors: Chandra, D.K., Reis, R.L., Kundu, S.C., Kumar, A., Mahapatra, C.
    Journal: ACS Biomaterials Science and Engineering, 2024, 10(7), pp. 4145–4174
  3. Title: Access to and quality of elective care: a prospective cohort study using hernia surgery as a tracer condition in 83 countries
    Authors: Dönmez, A.E., Goswami, A.G., Raheja, A., Osama, Z., Dauksa, Z.
    Journal: The Lancet Global Health, 2024, 12(7), pp. e1094–e1103
  4. Title: Development of the dynamic approach for detection of Salmonella Typhi biofilm via optimizations of interaction with safranin dye
    Authors: Upadhyay, A., Pal, D., Kumar, A.
    Journal: Biologia, 2024, 79(7), pp. 2299–2309
  5. Title: Application of Invasive Weed Biochar as Soil Amendment Improves Soil Organic Carbon Fractions and Yield of Fodder Oat in a Semi-Arid Region
    Authors: Prasad, M., Choudhary, P., Choudhary, M., Palsaniya, D.R., Kumar, S.
    Journal: Journal of Soil Science and Plant Nutrition, 2024, 24(2), pp. 2111–2122

Prof. Zhiguo Wang – Polypharmacology – Outstanding Scientist Award

Prof. Zhiguo Wang - Polypharmacology - Outstanding Scientist Award

Guangdong Provincial Key Laboratory for Mechanistic and Translational Research on Bidirectional Complications among Chronic Conditions, Jinan University, China - China 

Author Profile

SCOPUS 

ORCID

GOOGLE SCHOLAR

Early academic pursuits 🎓

Zhiguo Wang embarked on his academic journey with a strong foundation in pharmacology, pursuing his studies at Harbin Medical University in Heilongjiang, China. His early work laid the groundwork for a distinguished career focused on understanding chronic diseases and their complex interrelations. His rigorous training and commitment to research established him as a formidable scholar in the field of cardiovascular and chronic disease research.

Professional endeavors 🏢

Throughout his career, Zhiguo has held numerous prestigious positions, demonstrating his leadership in the medical and research communities. He is currently the Director and Professor at the Guangdong Provincial Key Laboratory for Mechanistic and Translational Research on Chronic Disease Complex Complications at Jinan University in Guangzhou, China. His role as a chief scientist and professor across various departments at the First Affiliated Hospital of Jinan University reflects his multifaceted expertise. Additionally, he has contributed significantly as a Distinguished Professor at Harbin Medical University and held a visiting professorship at the Montreal Heart Institute in Canada.

Contributions and research focus 🔬

Zhiguo's research focuses on the mechanistic and translational aspects of chronic diseases, particularly the bidirectional complications arising from these conditions. He has pioneered studies that explore the pathophysiology of cardiovascular diseases and their links to metabolic disorders. His work employs innovative Polypharmacology methodologies to investigate the underlying mechanisms of disease progression and to develop effective therapeutic strategies, aiming to improve patient outcomes in chronic disease management.

Accolades and recognition 🏅

Zhiguo Wang has received numerous accolades for his contributions to medical research, including being a Fellow of the American Heart Association (FAHA) and a Polypharmacology Fellow of the European Society of Cardiology (FESC). His recognition as a Marion L. Munro Research Scholar by the Canadian Diabetes Association further underscores his impactful research in chronic disease mechanisms. His extensive publication record in high-impact journals reflects his influence and standing in the academic community.

Impact and influence 🌍

Zhiguo's research has made a significant impact on the understanding of chronic diseases and their complications, influencing both clinical practice and public health strategies. His work is instrumental in bridging the gap between basic science and clinical applications, ultimately contributing to improved therapeutic approaches Polypharmacology for patients suffering from chronic conditions. He is a sought-after speaker and mentor, inspiring the next generation of researchers in his field.

Legacy and future contributions 🔮

As a leader in chronic disease research, Zhiguo Wang’s legacy is built on his commitment to advancing scientific knowledge and improving patient care. His ongoing research aims to unravel the complexities of chronic disease interactions and to foster innovative therapeutic strategies. With a focus on translational research, Zhiguo's future contributions are poised to drive significant advancements in understanding and treating chronic conditions, leaving a lasting impact on the field and enhancing healthcare outcomes globally.

Notable Publications 

Assist Prof Dr. Bing Liu – Drug testing and metabolic analysis – Best Researcher Award

Assist Prof Dr. Bing Liu - Drug testing and metabolic analysis - Best Researcher Award

shanghai university of Sport - China

Author Profile 

ORCID

Early academic pursuits 🎓

Bing Liu's academic journey began with a deep interest in chemistry and its applications in sports science. after completing his undergraduate studies, he pursued advanced degrees that allowed him to explore the intricate world of small molecule synthesis and stable isotope analysis. his academic foundation was laid in reputable institutions, where he developed a strong passion for doping detection and metabolomics, crucial areas in sports performance research.

Professional endeavors 🏛️

as an assistant professor at shanghai university of sport, bing liu has established himself as a dedicated educator and researcher. his role at the university involves not only teaching but also leading cutting-edge research projects in the field of sports science. his expertise in stable isotope analysis and doping detection has positioned him as a key figure in the fight against doping in sports, contributing significantly to the integrity of competitive athletics.

Contributions and research focus 🔬

Bing Liu's research is focused on isomer small molecule synthesis and the analysis of stable isotopes, with a special emphasis on doping Drug testing and metabolic analysis detection. his work in metabolomics and sports performance research has led to the development of novel methods for analyzing endogenous and exogenous substances in athletes. his recent publications in prestigious journals like the analyst and journal of chromatography a highlight his contributions to the purification of urinary prednisone and the detection of low-dose aicar in urine samples, using two-dimensional liquid chromatography techniques.

Accolades and recognition 🏅

Bing Liu's research has earned him recognition in the scientific community, particularly for his innovative approaches to doping detection and Drug testing and metabolic analysis stable isotope analysis. his work has been published in top-tier journals, where he has often served as the corresponding author, showcasing his leadership in these specialized fields. the significance of his contributions is reflected in the high-impact nature of his publications and the advancement of analytical techniques in sports science.

Impact and influence 🌍

the impact of bing liu's work extends beyond the laboratory. his research on doping detection plays a crucial role in maintaining fairness in Drug testing and metabolic analysis sports, ensuring that athletes compete on a level playing field. by advancing methods for detecting prohibited substances, he contributes to the credibility of sports organizations and the protection of athletes' health. his influence is seen in both the academic and athletic communities, where his work helps shape policies and practices related to doping control.

Legacy and future contributions 🔮

Bing Liu is poised to leave a lasting legacy in the fields of sports science and analytical chemistry. his pioneering research in stable isotope analysis and doping detection continues to evolve, with future contributions likely to further enhance the accuracy and reliability of doping tests. as he continues to mentor the next generation of scientists and athletes, his legacy will be defined by his commitment to excellence and the integrity of sports.

Notable Publications

Dr. Hina Khalid – Biotechnology – Best Researcher Award

Dr. Hina Khalid - Biotechnology - Best Researcher Award

Shandong University of Technology - China

Professional Profile

SCOPUS

ORCID 

Early Academic Pursuits

Dr. Hina Khalid began her academic journey with a Bachelor of Science (BS) Honours in Bioinformatics from Government College University, Faisalabad, followed by a Master of Science (MS) in Biotechnology. She completed her Ph.D. in Biotechnology from the same institution in 2021, focusing on innovative approaches in molecular biology and immunoinformatics.

Professional Endeavors

Dr. Khalid's research career has been marked by significant contributions across various institutions. She served as a Research Associate at Government College University, Faisalabad, where she led projects investigating the therapeutic potential of synthetic compounds against Biotechnology Hepatitis C Virus (HCV). Her work integrated insilico approaches with experimental validations, employing molecular docking, Real-Time PCR, and western blotting techniques.

Contributions and Research Focus

Dr. Khalid's research interests span a wide array of disciplines within biotechnology and molecular biology. She has expertise in cell biology, microscopy/imaging, immunology, biochemistry, genomics, and bioinformatics. Her notable contributions include the development of novel Biotechnology therapies for HCV, insights into cancer stem cells in hepatocellular cancer, and the design of multi-epitope vaccines against viral infections using immunoinformatics approaches.

Accolades and Recognition

Dr. Khalid's research has been widely recognized through numerous publications in high-impact journals and several awards. She has authored papers on topics ranging from viral infections to cancer biology, showcasing her expertise in elucidating complex biological mechanisms and Biotechnology developing therapeutic interventions.

Impact and Influence

Dr. Khalid's work has had a profound impact on the fields of biotechnology and immunoinformatics, particularly in advancing the understanding of viral diseases and cancer biology. Her contributions in designing novel therapeutic strategies and vaccines reflect her commitment to Biotechnology addressing global health challenges through innovative research.

Legacy and Future Contributions

Dr. Khalid's legacy is characterized by her pioneering research in immunoinformatics and molecular biology, aimed at developing targeted therapies and vaccines. Her future contributions are poised to continue pushing the boundaries of biotechnological research, with a focus on enhancing disease prevention and treatment strategies. As she progresses in her career, Dr. Khalid remains dedicated to leveraging her Biotechnology expertise to make transformative advancements in healthcare and biotechnology.

NOTABLE PUBLICATIONS

Calcineurin and mTOR inhibitors in kidney transplantation: integrative metamodeling on transplant  2024